Taken together, these in vitro effects suggest that silencing of PCDHB15 in melanoma cells participates in the fine-tuning of the aggregative behavior of melanoma cells during melanoma progression and favors specific metastatic properties. This evidence concerns the gene PCDHB15 and melanoma.